What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA approved first-in-class rusfertide (Mimrylo) for treating erythrocytosis in adults with polycythemia vera (PV), a rare and slow-growing hematologic malignancy. Rusfertide mimics hepcidin, the natural hormone involved...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
About 20% of adults living in Medicaid expansion states will have their eligibility threatened because their work hours may be insufficient or inconsistent under incoming national work requirements, a…
The Democratic Republic of Congo has recorded more than 6,000 confirmed cases and nearly 3,000 deaths from the country's worst Ebola epidemic ever, according to the Congolese authorities' latest toll…
Some cancer medicines will cost less than Ksh50,000 per cycle, down from as much as Ksh1 million. The post Cancer drug prices set to drop as Kenya seals deal with Pfizer appeared first on KBC Digital…
"Our goal is to both extend the survival of our brain tumor patients and improve the quality of their lives."
Several USDA-supported cyclospora research projects are reportedly being shuttered after losing federal funding.
